New program helps diabetics master glucose monitors

NCT ID NCT04672655

Completed Symptom relief Sponsor: Molly Tanenbaum Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested a behavioral program called ONBOARD for 150 adults with type 1 diabetes who were not using continuous glucose monitors regularly. The program taught skills to overcome common barriers like managing data and social situations. The goal was to help participants better control their blood sugar and prepare for advanced diabetes technology.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (ONBOARD program)
What this could lead to: If successful, this program could help adults with type 1 diabetes feel more comfortable and confident using continuous glucose monitors, leading to better blood sugar management.
What could go wrong: This is a small, completed behavioral study with 150 participants, so results may not apply to everyone. The program focuses on device use, not a cure or new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Show contact details

Locations

Stanford University

Stanford, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.